ASNS and acute lymphoblastic leukemia: ASNS expression has been proposed as a marker for clinical prediction of ASNase resistance (Scherf et al, 2000); however, treatment of ALL with ASNase is still effective even though ASNS is expressed (Stams, 2003; Krall et al, 2016; Vander Heiden & DeBerardinis, 2017).